-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUPHORIA THERAPEUTICS - SCANCELL SHAREHOLDERS TO OWN 85.5%, NEUPHORIA SHAREHOLDERS 14.5% OF COMBINED COMPANY

Reuters·07/23/2026 10:11:37

Please log in to view news